Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects

2016 ◽  
Vol 48 (11) ◽  
pp. 1391-1393 ◽  
Author(s):  
Philippe A.R.R. Pijls ◽  
Lennard P.L. Gilissen
Keyword(s):  
Inflammatory Bowel Disease ◽  
Side Effects ◽  
Bowel Disease ◽  
Effective Alternative ◽  
Tnf Alpha ◽  
Inflammatory Bowel ◽  
Dermatological Side Effects ◽  
Alpha Therapy

Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy

2017 ◽  
Vol 40 (2) ◽  
pp. 117-121
Author(s):  
Ainara Iriarte ◽  
Celia Zaera ◽  
Javier Bachiller-Corral ◽  
Antonio López-Sanromán
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Tnf Alpha ◽  
Paradoxical Effect ◽  
Inflammatory Bowel ◽  
Alpha Therapy

Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease

2020 ◽  
Vol 52 (4) ◽  
pp. 400-407 ◽  
Author(s):  
Alfredo J Lucendo ◽  
Óscar Roncero ◽  
María Teresa Serrano-Duenas ◽  
Daniel Hervías ◽  
Luis Miguel Alcázar ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Tnf Alpha ◽  
Inflammatory Bowel ◽  
Alpha Therapy

scholarly journals Response to Influenza Vaccine a/H1N1 2009 in Patients With Inflammatory Bowel Disease on Anti TNF-Alpha Therapy

2011 ◽  
Vol 140 (5) ◽  
pp. S-274
Author(s):  
Gianluca Andrisani ◽  
Daniela Frasca ◽  
Alessandro Armuzzi ◽  
Alfredo Papa ◽  
Manuela Marzo ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccine ◽  
Bowel Disease ◽  
Tnf Alpha ◽  
Inflammatory Bowel ◽  
Alpha Therapy
Sign in / Sign up

Export Citation Format

Share Document